Landec Corporation Sets Fourth Quarter 2021 Earnings Conference Call for July 28, 2021 at 2 p.m. PT

Rhea-AI Summary

Landec Corporation (Nasdaq: LNDC) will hold a conference call on July 28, 2021, at 2 p.m. Pacific Time to discuss its fiscal fourth quarter 2021 results. The results, covering the period ending May 31, 2021, will be announced after market close on the same day. The call will feature CEO Dr. Albert Bolles, CFO John Morberg, and Lifecore President Jim Hall, followed by a Q&A session. Interested parties can access the call via telephone or webcast, with a replay available for a week after the event.

Positive

• Scheduled conference call to discuss fiscal Q4 results could indicate transparency and engagement with investors.
• Involvement of key executives like the CEO and CFO demonstrates leadership commitment to stakeholder communication.

Negative

• None.

SANTA MARIA, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc., will hold a conference call on Wednesday, July 28, 2021 at 2 p.m. Pacific time to discuss its results for the fiscal fourth quarter 2021. Financial results will be reported for the 2021 fiscal fourth quarter ended May 31, 2021 after market close on July 28, 2021.

Landec's President and CEO, Dr. Albert Bolles, will host the Conference Call with John Morberg, Chief Financial Officer and Jim Hall, Lifecore President. A question and answer period will follow the presentation.

Date: Wednesday, July 28, 2021
Time: 2 p.m. Pacific time (5 p.m. Eastern time)
Toll Free Participant Dial-in Number: 1-877-407-3982
U.S. and International Toll Number: 1-201-493-6780
Conference ID: 13721180
Webcast: http://ir.Landec.com/events.cfm
The webcast will be available for 30 days through August 27, 2021.

A replay of the teleconference will be available for one week until midnight Eastern Time on Wednesday, August 4, 2021.
Toll free replay dial in: 1-844-512-2921
International replay: 1-412-317-6671
Replay passcode: 13721180

About Landec Corporation

Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Lifecore Biomedical, Inc. and Curation Foods, Inc. Landec designs, develops, manufactures and sells products for the biopharmaceutical and food industries. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, Yucatan® and Cabo Fresh® avocado products and O Olive Oil & Vinegar® premium artisan products. For more information about the Company, visit Landec’s website at www.landec.com. 

Contact Information:
Investor Relations:
Jeff Sonnek
(646) 277-1263
jeff.sonnek@icrinc.com 

FAQ

What are the details of Landec Corporation's upcoming conference call?

Landec Corporation's conference call will occur on July 28, 2021, at 2 p.m. Pacific Time to discuss Q4 fiscal 2021 results.

When will Landec report its fiscal fourth quarter results?

Landec will report its fiscal fourth quarter results on July 28, 2021, after market close.

Who will participate in Landec's conference call?

CEO Dr. Albert Bolles, CFO John Morberg, and Lifecore President Jim Hall will participate in the conference call.

How can I access the Landec Corporation conference call?

The conference call can be accessed via phone at 1-877-407-3982 or through a webcast on Landec's investor relations site.